Anti-inflammatory effects of β2 adrenergic receptor agonists in experimental acute lung injury

FASEB Journal

Volumn 26, Issue 5, 2012, Pages 2137-2144

  Bosmann, Markus ^a   Grailer, Jamison J ^a   Zhu, Ketong ^a   Matthay, Michael A ^b   Sarma, J Vidya ^a   Zetoune, Firas S ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albuterol; Formoterol; JNK; Macrophages; Neutrophils

Indexed keywords

ALBUMIN; BETA 2 ADRENERGIC RECEPTOR; FORMOTEROL; SALBUTAMOL; STRESS ACTIVATED PROTEIN KINASE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENANTIOMER; ENZYME PHOSPHORYLATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ACUTE LUNG INJURY; ADRENERGIC BETA-AGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; MALE; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MUS;

EID: 84860894209     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-201640     Document Type: Article

References (42)

1. Matthay, M. A., and Zimmerman, G. A. (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am. J. Respir. Cell Mol. Biol. 33, 319-327 (Pubitemid 41416281)
2. Goss, C. H., Brower, R. G., Hudson, L. D., and Rubenfeld, G. D. (2003) Incidence of acute lung injury in the United States. Crit. Care Med. 31, 1607-1611 (Pubitemid 36714211)
3. Sakuma, T., Folkesson, H. G., Suzuki, S., Okaniwa, G., Fujimura, S., and Matthay, M. A. (1997) Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am. J. Respir. Crit. Care Med. 155, 506-512 (Pubitemid 27085793)
4. Sakuma, T., Okaniwa, G., Nakada, T., Nishimura, T., Fujimura, S., and Matthay, M. A. (1994) Alveolar fluid clearance in the resected human lung. Am. J. Respir. Crit. Care Med. 150, 305-310 (Pubitemid 24252335)
5. Tracey, K. J. (2009) Reflex control of immunity. Nat. Rev. Immunol. 9, 418-428
6. Flierl, M. A., Rittirsch, D., Nadeau, B. A., Chen, A. J., Sarma, J. V., Zetoune, F. S., McGuire, S. R., List, R. P., Day, D. E., Hoesel, L. M., Gao, H., Van Rooijen, N., Huber-Lang, M. S., Neubig, R. R., and Ward, P. A. (2007) Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725 (Pubitemid 47552095)
7. Dutta, E. J., and Li, J. T. (2002) Beta-agonists. Med. Clin. North. Am. 86, 991-1008
8. Sartori, C., Allemann, Y., Duplain, H., Lepori, M., Egli, M., Lipp, E., Hutter, D., Turini, P., Hugli, O., Cook, S., Nicod, P., and Scherrer, U. (2002) Salmeterol for the prevention of high-altitude pulmonary edema. N. Engl. J. Med. 346, 1631-1636 (Pubitemid 34755671)
9. McAuley, D. F., Frank, J. A., Fang, X., and Matthay, M. A. (2004) Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit. Care Med. 32, 1470-1476 (Pubitemid 38925174)
10. Chen, F., Nakamura, T., Fujinaga, T., Zhang, J., Hamakawa, H., Omasa, M., Sakai, H., Hanaoka, N., Bando, T., Wada, H., and Fukuse, T. (2006) Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs. Ann. Thorac. Surg. 82, 465-471 (Pubitemid 44080011)
11. Maris, N. A., de Vos, A. F., Dessing, M. C., Spek, C. A., Lutter, R., Jansen, H. M., van der Zee, J. S., Bresser, P., and van der Poll, T. (2005) Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am. J. Respir. Crit. Care Med. 172, 878-884 (Pubitemid 41369072)
12. Bosmann, M., Patel, V. R., Russkamp, N. F., Pache, F., Zetoune, F. S., Sarma, J. V., and Ward, P. A. (2011) MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway. FASEB J. 25, 4222-4232
13. Bosmann, M., Russkamp, N. F., Patel, V. R., Zetoune, F. S., Sarma, J. V., and Ward, P. A. (2011) The outcome of polymicrobial sepsis is independent of T and B cells. Shock 36, 396-401
14. Rittirsch, D., Flierl, M. A., Day, D. E., Nadeau, B. A., McGuire, S. R., Hoesel, L. M., Ipaktchi, K., Zetoune, F. S., Sarma, J. V., Leng, L., Huber-Lang, M. S., Neff, T. A., Bucala, R., and Ward, P. A. (2008) Acute lung injury induced by lipopolysaccharide is independent of complement activation. J. Immunol. 180, 7664-7672
15. Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., Gebhard, F., Younger, J. G., Drouin, S. M., Wetsel, R. A., and Ward, P. A. (2006) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682-687 (Pubitemid 43865238)
16. Gao, H., Neff, T., and Ward, P. A. (2006) Regulation of lung inflammation in the model of IgG immune-complex injury. Annu. Rev. Pathol. 1, 215-242
17. Shanley, T. P., Schmal, H., Warner, R. L., Schmid, E., Friedl, H. P., and Ward, P. A. (1997) Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complexinduced lung injury. J. Immunol. 158, 3439-3448 (Pubitemid 127484065)
18. Warren, J. S., Yabroff, K. R., Remick, D. G., Kunkel, S. L., Chensue, S. W., Kunkel, R. G., Johnson, K. J., and Ward, P. A. (1989) Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84, 1873-1882 (Pubitemid 20016193)
19. Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., and Anderson, D. W. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98, 13681-13686 (Pubitemid 33115958)
20. Johnson, M. (1998) The beta-adrenoceptor. Am. J. Respir. Crit. Care. Med. 158, S146-S53
21. Mutlu, G. M., and Factor, P. (2008) Alveolar epithelial beta2-adrenergic receptors. Am. J. Respir. Cell Mol. Biol. 38, 127-134
22. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822
23. Whelan, C. J., Johnson, M., and Vardey, C. J. (1993) Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung. Br. J. Pharmacol. 110, 613-618 (Pubitemid 23279268)
24. Matthay, M. A., and Abraham, E. (2006) Beta-adrenergic agonist therapy as a potential treatment for acute lung injury. Am. J. Respir. Crit. Care Med. 173, 254-255 (Pubitemid 43209077)
25. Manocha, S., Gordon, A. C., Salehifar, E., Groshaus, H., Walley, K. R., and Russell, J. A. (2006) Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit. Care 10, R12
26. Mutlu, G. M., and Sznajder, J. I. (2005) Mechanisms of pulmonary edema clearance. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L685-L695 (Pubitemid 41504397)
27. Spoelstra, F. M., Postma, D. S., Hovenga, H., Noordhoek, J. A., and Kauffman, H. F. (2002) Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 57, 237-241 (Pubitemid 34214410)
28. Scola, A. M., Loxham, M., Charlton, S. J., and Peachell, P. T. (2009) The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells. Br. J. Pharmacol. 158, 267-276
29. Perkins, G. D., McAuley, D. F., Richter, A., Thickett, D. R., and Gao, F. (2004) Bench-to-bedside review: beta2-agonists and the acute respiratory distress syndrome. Crit. Care 8, 25-32 (Pubitemid 38195567)
30. Dhingra, V. K., Uusaro, A., Holmes, C. L., and Walley, K. R. (2001) Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury. Anesthesiology 95, 947-953 (Pubitemid 32939120)
31. Oddera, S., Silvestri, M., Lantero, S., Sacco, O., and Rossi, G. A. (1998) Downregulation of the expression of intercellular adhesion molecule (ICAM)-1 on bronchial epithelial cells by fenoterol, a beta2-adrenoceptor agonist. J. Asthma 35, 401-408 (Pubitemid 28438359)
32. Bloemen, P. G., van den Tweel, M. C., Henricks, P. A., Engels, F., Kester, M. H., van de Loo, P. G., Blomjous, F. J., and Nijkamp, F. P. (1997) Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am. J. Physiol. Lung Physiol. 272, L580-L587
33. Sabatini, F., Silvestri, M., Sale, R., Serpero, L., Di Blasi, P., and Rossi, G. A. (2003) Cytokine release and adhesion molecule expression by stimulated human bronchial epithelial cells are downregulated by salmeterol. Respir. Med. 97, 1052-1060 (Pubitemid 37098771)
34. Queen, L. R., Ji, Y., Xu, B., Young, L., Yao, K., Wyatt, A. W., Rowlands, D. J., Siow, R. C., Mann, G. E., and Ferro, A. (2006) Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J. Physiol. 576, 585-594 (Pubitemid 44490147)
35. Zink, S., Rosen, P., and Lemoine, H. (1995) Micro- and macro-vascular endothelial cells in beta-adrenergic regulation of transendothelial permeability. Am. J. Physiol. Cell Physiol. 269, C1209-C1218
36. Cobelens, P. M., Kavelaars, A., Vroon, A., Ringeling, M., van der Zee, R., van Eden, W., and Heijnen, C. J. (2002) The beta 2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity. J. Immunol. 169, 5028-5035 (Pubitemid 35217171)
37. Roux, F. J., Grandordy, B., and Douglas, J. S. (1996) Functional and binding characteristics of long-acting beta 2-agonists in lung and heart. Am. J. Respir. Crit. Care Med. 153, 1489-1495 (Pubitemid 26141330)
38. Donnelly, L. E., Tudhope, S. J., Fenwick, P. S., and Barnes, P. J. (2010) Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur. Respir. J. 36, 178-186
39. Atabai, K., Ware, L. B., Snider, M. E., Koch, P., Daniel, B., Nuckton, T. J., and Matthay, M. A. (2002) Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med. 28, 705-711 (Pubitemid 34639482)
40. Perkins, G. D., McAuley, D. F., Thickett, D. R., and Gao, F. (2006) The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am. J. Respir. Crit. Care Med. 173, 281-287 (Pubitemid 43209082)
41. Matthay, M. A., Brower, R. G., Carson, S., Douglas, I. S., Eisner, M., Hite, D., Holets, S., Kallet, R. H., Liu, K. D., MacIntyre, N., Moss, M., Schoenfeld, D., Steingrub, J., and Thompson, B. T. (2011) Randomized, placebo-controlled clinical trial of an aerosolized beta-agonist for treatment of acute lung injury. Am. J. Respir. Crit. Care Med. 184, 561-568
42. Levitt, J. E., Bedi, H., Calfee, C. S., Gould, M. K., and Matthay, M. A. (2009) Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest 135, 936-943